19 June 2013
Keywords: zeltia, yondelis, enters, phase, iii, drug, major
Article | 09 April 2007
US drug major Wyeth has completed the purchase of the final 20% stake of Wyeth KK from Japanese drug major Takeda, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
9 April 2007
16 April 2007
© 2013 thepharmaletter.com